Navigation Links
Wilson Sonsini Goodrich & Rosati Opens Hong Kong Office
Date:10/24/2010

HONG KONG and PALO ALTO, Calif., Oct. 24 /PRNewswire/ -- Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, is pleased to announce that it has opened an office in Hong Kong.

(Logo: http://photos.prnewswire.com/prnh/20040225/SFWSGRLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20040225/SFWSGRLOGO)

"China is an incredibly vibrant market—one that we have been focused on and investing in for many years," said CEO Steve Bochner. "Given Hong Kong's position as a leading global financial center and the preferred overseas capital market for many Chinese enterprises, it is the logical place for us to open our second office in China. There are also considerable synergies between Hong Kong and the work we already are doing in China. We are extremely pleased to have found the right team and leadership to anchor our Hong Kong office, and look forward to continuing to build our presence in the Greater China region."

"This is a very exciting time to be in China," said Carmen Chang, who will oversee the firm's Hong Kong office as Senior Resident Partner. "World-class companies continue to form, entrepreneurialism is on the rise, and the economy is exceptionally strong. In the past several years, we have been fortunate enough to work with many outstanding, talented clients, and the establishment of a Hong Kong office will allow us to serve them even more effectively and significantly grow our China practice."  

The Hong Kong team will be led by Weiheng Chen, who co-heads the firm's China practice along with Carmen Chang. He recently joined the firm from Milbank, Tweed, Hadley, and McCloy and has particular expertise in private equity, mergers and acquisitions, and capital markets. The Hong Kong team will work closely with the firm's attorneys in Shanghai and the U.S. The China practice represents clients in a variety of legal matters in the Gr
'/>"/>

SOURCE Wilson Sonsini Goodrich & Rosati
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Jerome Wilson Joins PRA Internationals Late Phase Service Group
2. Dynamic Ventures Corporations Information To Be Available Through Standard & Poors Market Access Program
3. WAVE Conference and Exhibition 2011 Taking Products to Market incorporating Micro & Nano Technology
4. Burrill & Company CEO and Genzyme Executive Join BVGH Board of Directors
5. Genesis Biopharma to Present at the Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference on October 13
6. Reportlinker Adds Biobanking for Medical R&D: Technology and Market 2010-2025
7. Johnson & Johnson and Crucell Reach Agreement on Intended Public Offer of Euro 24.75 per Ordinary Share of Crucell
8. Vaccinogen Names Veteran Biotech Executive Michael Kranda President & CEO
9. ISTA Pharmaceuticals Highlights Clinical Data from REMURAâ„¢ Phase 2 Study Presented at the 6th International Conference on the Tear Film & Ocular Surface
10. Kincannon & Reed Promotes Jon Leafstedt to Managing Partner
11. Frost & Sullivan Commends Isobionics for Technology Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 24, 2014 The report expects global ... by 2019. It also provides a carefully analyzed data ... challenges for the market. , Full Copy of Report ... the global market for cell expansion will keep witnessing ... expects this growth to be driven by rapid technological ...
(Date:12/24/2014)... , Dec. 23, 2014 Vermillion, ... focused on gynecologic disease, announced today that investors ... , Birchview Fund LLC and several Vermillion directors ... unregistered shares of Vermillion,s common stock and warrants ... in a private placement.  Under ...
(Date:12/24/2014)... -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI ) ... Application (CTA) with the United Kingdom,s ... approval to initiate clinical trials for the continued development ... on the Company receiving CTA regulatory approval, the Company ... the safety, tolerability and dose escalation of Anatabine Citrate ...
(Date:12/22/2014)... 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, with ... announced positive topline safety and tolerability results ... SYN-004, the Company,s investigational oral beta-lactamase enzyme ... (C. difficile) infection, antibiotic-associated diarrhea and ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
... Sept. 16 Genoptix, Inc.,(Nasdaq: GXDX ), a ... the UBS Global Life Sciences Conference,scheduled to take place ... September 22,- 25, 2008., Douglas Schuling, Senior Vice ... on Monday, September 22, beginning at,approximately 3:30 pm EDT. ...
... answer to ensuring a safe supply of drinking water ... or where water contamination is rife. Writing in the ... India explain how carbon nanotubes could replace conventional materials ... access to safe drinking water will continue to grow ...
... Symmetry Medical Inc.,(NYSE: SMA ), a leading ... and other medical markets, announced today that,Brian S. Moore, ... the UBS Global Life Sciences Conference at The Grand ... 25, 2008 at 11:30 a.m. ET., A live ...
Cached Biology Technology:Genoptix Announces Participation at the UBS Global Life Sciences Conference 2Water purification down the nanotubes 2Symmetry Medical to Present at UBS Global Life Sciences Conference 2
(Date:12/17/2014)... DUBLIN , Dec. 15, 2014 Research ... announced the addition of the "Samsung Galaxy ... Analysis" report to their offering. ... on a totally different sensing technology than the ... a fingerprint sensor in its product. ...
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance ... technology to industry leaders such as Intel, Jabra, Atlas, ... biometric wearable products. These products will be showcased at ... Las Vegas . "Our partners ... and robust – with the clinical data to back ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... ON (Dec. 22, 2011) - Drugs used to overcome ... study led by Gerry Wright, scientific director of the ... McMaster University. "Our study found that certain proteins, ... to proteins important in cancer," says Wright about the ...
... 2011(BRONX, NY) Researchers at Albert Einstein College of Medicine ... mechanism by which cells control the survival of messenger RNA ... pertain to mRNAs that help regulate cell division and could ... research is described in today,s online edition of the journal ...
... tragic losses to life, property, and the environment. But ... from done. Without vegetation, bare, burnt soil lies vulnerable ... regeneration. Now Assaf Inbar, a graduate student ... together with his supervisors Prof. Marcelo Sternberg of the ...
Cached Biology News:Built-in 'self-destruct timer' causes ultimate death of messenger RNA in cells 2Built-in 'self-destruct timer' causes ultimate death of messenger RNA in cells 3Reclaiming the land after a forest fire 2
... use spatulas have been designed to save ... for those interested in eliminating the recycling ... spatula is individually packaged, RNase/DNase free, non-pyrogenic ... a new product number, created to easily ...
... have been designed to save time and ... interested in eliminating the recycling and resterilizing ... individually packaged, RNase/DNase free, non-pyrogenic and antistatic. ... product number, created to easily match Cornings ...
... Phosphatase Detection Kit (Catalog number SCR004) is ... phenotypic assessment of ES cell differentiation by ... separately from CHEMICON are the monoclonal antibodies ... Number MAB4354), which permit the detection of ...
... The SYS203 is a complete, ... measurement in small samples, as is ... system is designed around Instechs miniature ... of an inch in diameter (3.2 ...
Biology Products: